88677074 - SMARTDOSE

Information

  • Trademark
  • 88677074
  • Serial Number
    88677074
  • Filing Date
    November 01, 2019
    5 years ago
  • Transaction Date
    March 04, 2024
    11 months ago
  • Status Date
    March 04, 2024
    11 months ago
  • Published for Opposition Date
    June 01, 2021
    3 years ago
  • Location Date
    July 27, 2021
    3 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    SIMCOX, KYLE DUNCAN
  • Attorney Docket Number
    WESM-199US1
    Attorney Name
    Rex A. Donnelly
    Law Office Assigned Location Code
    N40
  • Owners
Mark Drawing Code
5000
Mark Identification
SMARTDOSE
Case File Statements
  • DM0000: The mark consists of the stylized wording "SMARTDOSE" with "SMART" in light blue relatively thicker letters, "DOSE" in gray relatively thinner letters, and the bar of the "E" in light blue and detached from the stem.
  • GS0091: downloadable computer application software for mobile phones and handheld computers, namely, interactive patient engagement and medication adherence software for users of wearable injector drug delivery systems; downloadable computer software for facilitating communication between a computer or handheld device connected to the internet and an wearable injector drug delivery system; downloadable mobile applications for communicating with an wearable injector drug delivery system and for displaying health related information
  • GS0051: Infusion pumps, sold pre-filled, for facilitating subcutaneous delivery of a wide range of liquid pharmaceutical preparations to patients; infusion pumps sold pre-filled with fluids used for the subcutaneous delivery of pharmaceutical preparations to patients; infusion pumps for delivering liquid pharmaceutical preparations to patients, sold pre-filled with pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; infusion pumps for delivering liquid pharmaceutical preparations to patients, sold pre-filled with insulin
  • GS0381: telecommunications services, namely, providing e-mail and text messages notification via the internet, featuring alerts, reminders and information related to compliance with health programs relating to wearable injector drug delivery systems
  • PM0001: SMART DOSE
  • CC0000: The color(s) light blue and gray is/are claimed as a feature of the mark.
  • GS0351: arranging and conducting incentive reward programs for promoting consumer compliance with prescriptions for medications delivered by wearable injector drug delivery systems; promoting data collection used in improving healthcare administration and cost management in connection with wearable injector drug delivery systems by providing an interactive web site where users can provide information about health and fitness in the nature of their health programs, personal health data and prescription and health conditions, in exchange for promotional rewards consisting of discounts and special offerings on goods and/or services provided by website sponsors
  • GS0441: Providing health care information relating to wearable injector drug delivery systems by global computer networks and electronic means
  • GS0421: Computer services, namely, providing an interactive web site featuring technology that allows users to communicate information from wearable injector drug delivery systems; Providing temporary use of non-downloadable computer software for communicating with wearable injector drug delivery systems and for displaying health related information; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports relating to wearable injector drug delivery systems; Providing on-line non-downloadable software for authenticating and rewarding compliance with health programs, namely, prescriptions for medications and medical treatment regimens related to wearable injector drug delivery systems; Providing on-line non-downloadable software for users to receive notifications via e-mail, instant message, short message service (SMS), multimedia message service (MMS) or text messages relating to wearable injector drug delivery systems; Research and development and consultation related thereto in the field of wearable injector drug delivery systems
Case File Event Statements
  • 3/4/2024 - 11 months ago
    42 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 3/4/2024 - 11 months ago
    41 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 7/29/2023 - a year ago
    40 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/27/2023 - a year ago
    39 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 7/27/2023 - a year ago
    38 - SOU EXTENSION 4 FILED Type: EXT4
  • 7/27/2023 - a year ago
    37 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/6/2023 - 2 years ago
    36 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/4/2023 - 2 years ago
    35 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 1/4/2023 - 2 years ago
    34 - SOU EXTENSION 3 FILED Type: EXT3
  • 1/4/2023 - 2 years ago
    33 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/29/2022 - 2 years ago
    32 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/27/2022 - 2 years ago
    31 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 7/27/2022 - 2 years ago
    30 - SOU EXTENSION 2 FILED Type: EXT2
  • 7/27/2022 - 2 years ago
    29 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/28/2022 - 3 years ago
    28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/26/2022 - 3 years ago
    27 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 1/26/2022 - 3 years ago
    26 - SOU EXTENSION 1 FILED Type: EXT1
  • 1/26/2022 - 3 years ago
    25 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/27/2021 - 3 years ago
    24 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 6/1/2021 - 3 years ago
    23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/1/2021 - 3 years ago
    22 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/12/2021 - 3 years ago
    21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/23/2021 - 3 years ago
    20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/21/2021 - 3 years ago
    19 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/21/2021 - 3 years ago
    18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/21/2021 - 3 years ago
    17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/21/2021 - 3 years ago
    16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/8/2021 - 3 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/8/2021 - 3 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/8/2021 - 3 years ago
    13 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 10/14/2020 - 4 years ago
    12 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 10/14/2020 - 4 years ago
    11 - FINAL REFUSAL E-MAILED Type: GNFR
  • 10/14/2020 - 4 years ago
    10 - FINAL REFUSAL WRITTEN Type: CNFR
  • 8/15/2020 - 4 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/14/2020 - 4 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/14/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/14/2020 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/14/2020 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/14/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/6/2020 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/6/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/5/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP